Engagement of Toll-like receptor 2 in mouse macrophages infected with Mycobacterium avium induces non-oxidative and TNF-independent anti-mycobacterial activity

European Journal of Immunology

Volumn 38, Issue 8, 2008, Pages 2180-2189

  Salome Gomes M ^a,b   Fernandes, Sofia Sousa ^a   Cordeiro, João V ^a   Gomes, Sandro Silva ^a   Vieira, André ^a   Appelberg, Rui ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Immunity; Nitric oxide; Phagocytes

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LIPOPROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; SUPEROXIDE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR; MYD88 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR6 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM AVIUM; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; SUPEROXIDES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51149087071     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737954     Document Type: Article

References (65)

1. Janssens, S. and Beyaert, R., Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 2003. 16: 637-646.
2. Medzhitov, R. and Janeway, C. A. Jr., Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997. 91: 295-298.
3. Medzhitov, R., Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001. 1: 135-145.
4. Medzhitov, R. and Janeway, C. Jr., Innate immune recognition: Mechanisms and pathways. Immunol. Rev. 2000. 173: 89-97.
5. Akira, S., Takeda, K. and Kaisho, T., Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2001. 2: 675-680.
6. Dunne, A. and O'Neill, L. A., Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett. 2005. 579: 3330-3335.
7. Feng, C. G., Scanga, C. A., Collazo-Custodio, C. M., Cheever, A.W., Hieny, S., Caspar, P. and Sher, A., Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)-and TLR4-deficient animals. J. Immunol. 2003. 171: 4758-4764.
8. Gomes, M. S., Flórido, M., Cordeiro, J. V., Teixeira, C. M., Takeuchi, O., Akira, S. and Appelberg, R., Limited role of the Toll-like receptor-2 in resistance to Mycobacterium avium. Immunology 2004. 111: 179-185.
9. Akira, S. and Takeda, K., Toll-like receptor signaling. Nat. Rev. Immunol. 2004. 4: 499-511.
10. Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L. and Aderem, A., The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 2000. 97: 13766-13771.
11. Underhill, D. M. and Ozinsky, A., Toll-like receptors: Key mediators of microbe detection. Curr. Opin. Immunol. 2002. 14: 103-110.
12. Morr, M., Takeuchi, O., Akira, S., Simon, M. M. and Muhlradt, P. F., Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 2002. 32: 3337-3347.
13. Takeuchi, O., Kawai, T., Muhlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K. and Akira, S., Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001. 13: 933-940.
14. Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L. and Akira, S., Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002. 169: 10-14.
15. Krutzik, S. R., Ochoa, M. T., Sieling, P. A., Uematsu, S., Ng, Y. W., Legaspi, A., Liu, P. T. et al., Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 2003. 9: 525-532.
16. Lien, E., Sellati, T. J., Yoshimura, A., Flo, T. H., Rawadi, G., Finberg, R. W., Carroll, J. D. et al., Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 1999. 274: 33419-33425.
17. Underhill, D. M., Ozinsky, A., Smith, K. D. and Aderem, A., Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 1999. 96: 14459-14463.
18. Wang, T., Lafuse,W. P. and Zwilling, B. S., Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol. 2000. 165: 6308-6313.
19. Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M. and Aderem, A., The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999. 401: 811-815.
20. Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R. B., Belisle, J. T., Bleharski, J. R., Maitland, M. et al., Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999. 285: 732-736.
21. Gehring, A. J., Dobos, K. M., Belisle, J. T., Harding, C. V. and Boom, W. H., Mycobacterium tuberculosis LprG (Rv1411c): A novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 2004. 173: 2660-2668.
22. Means, T. K., Lien, E., Yoshimura, A., Wang, S., Golenbock, D. T. and Fenton, M. J., The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 1999. 163: 6748-6755.
23. Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T. and Fenton, M. J., Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 1999. 163: 3920-3927.
24. Noss, E. H., Pai, R. K., Sellati, T. J., Radolf, J. D., Belisle, J., Golenbock, D. T., Boom, W. H. and Harding, C. V., Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 2001. 167: 910-918.
25. Thoma-Uszynski, S., Stenger, S., Takeuchi, O., Ochoa, M. T., Engele, M., Sieling, P. A., Barnes, P. F. et al., Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001. 291: 1544-1547.
26. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T. et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006. 311: 1770-1773.
27. Sweet, L. and Schorey, J. S., Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner. J. Leukoc. Biol. 2006. 80: 415-423.
28. Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Muhlradt, P. F. and Akira, S., Cutting edge: Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 2000. 164: 554-557.
29. Appelberg, R. and Orme, I. M., Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 1993. 80: 352-359.
30. Aliprantis, A. O., Weiss, D. S. and Zychlinsky, A., Toll-like receptor-2 transduces signals for NF-kappa B activation, apoptosis and reactive oxygen species production. J. Endotoxin Res. 2001. 7: 287-291.
31. Flo, T. H., Halaas, O., Lien, E., Ryan, L., Teti, G., Golenbock, D. T., Sundan, A. and Espevik, T., Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 2000. 164: 2064-2069.
32. Jones, B. W., Means, T. K., Heldwein, K. A., Keen, M. A., Hill, P. J., Belisle, J. T. and Fenton, M. J., Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 2001. 69: 1036-1044.
33. Doherty, T. M. and Sher, A., Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 1997. 158: 4822-4831.
34. Ehlers, S., Kutsch, S., Benini, J., Cooper, A., Hahn, C., Gerdes, J., Orme, I., Martin, C. and Rietschel, E. T., NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 1999. 98: 313-323.
35. Gomes, M. S. and Appelberg, R., NRAMP1- or cytokine-induced bacteriostasis of Mycobacterium avium by mouse macrophages is independent of the respiratory burst. Microbiology 2002. 48: 3155-3160.
36. Gomes, M. S., Flórido, M., Pais, T. F. and Appelberg, R., Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 1999. 162: 6734-6739.
37. Sarmento, A. and Appelberg, R., Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. Infect. Immun. 1996. 64: 3224-3230.
38. Nathan, C. and Shiloh, M. U., Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 2000. 97: 8841-8848.
39. Rosenberger, C. M., Gallo, R. L. and Finlay, B. B., Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA 2004. 101: 2422-2427.
40. MacMicking, J. D., Taylor, G. A. and McKinney, J. D., Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003. 302: 654-659.
41. Blander, J. M. and Medzhitov, R., Regulation of phagosome maturation by signals from toll-like receptors. Science 2004. 304: 1014-1018.
42. Yates, R. M., and Russell, D. G., Phagosome maturation proceeds independently of stimulation of Toll-like receptors 2 and 4. Immunity 2005. 23: 409-417.
43. Appelberg, R., Macrophage nutriprive antimicrobial mechanisms. J. Leukoc. Biol. 2006. 79: 1117-1128.
44. Alonso, S., Pethe, K., Russell, D. G. and Purdy, G. E., Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. USA 2007. 104: 6031-6036.
45. Gehring, A. J., Rojas, R. E., Canaday, D. H., Lakey, D. L., Harding, C. V. and Boom, W. H., The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through Toll-like receptor 2. Infect. Immun. 2003. 71: 4487-4497.
46. Alvarez, G. R., Zwilling, B. S. and Lafuse, W. P., Mycobacterium avium inhibition of IFN-γ signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1β by mRNA stabilization. J. Immunol. 2003. 171: 6766-6773.
47. Fortune, S. M., Solache, A., Jaeger, A., Hill, P. J., Belisle, J. T., Bloom, B. R., Rubin, E. J., Ernst, J. D., Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms. J. Immunol. 2004. 172: 6272-6280.
48. Pathak, S. K., Basu, S., Basu, K. K., Banerjee, A., Pathak, S., Bhattacharyya, A., Kaisho, T. et al., Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 2007. 8: 610-618.
49. Quesniaux, V. J., Nicolle, D. M., Torres, D., Kremer, L., Guérardel, Y, Nigou, J., Puzo, G. et al., Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-indeoendent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J. Immunol. 2004. 172: 4425-4434.
50. Doz, E., Rose, S., Nigou, J., Gilleron, M., Puzo, G., Erard, F., Ryffel, B. and Quesniaux, V. F., Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 2007. 282: 26014-26025.
51. Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M. and Puzo, G., Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor. J. Immunol. 2001. 166: 7477-7485.
52. Geijtenbeek, T. B., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Van den Broucke-Grauls, C. M., Appelmelk, B., and van Kooyk, Y., Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 2003. 197: 7-17.
53. Endres, R., Luz, A., Schulze, H., Neubauer, H., Fütterer, A., Holland, S. M., Wagner, H. and Pfeffer, K., Listeriosis in p47(phox-/ -) and TRp55-/-mice: Protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 1997. 7: 419-432.
54. Gregory, S. H., Wing, E. J., Hoffman, R. A. and Simmons, R. L., Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J. Immunol. 1993. 150: 2901-2909.
55. Yamamoto, Y., Klein, T. W. and Friedman, H., Immunoregulatory role of nitric oxide in Legionella pneumophila-infected macrophages. Cell. Immunol. 1996. 171, 231-239.
56. Gebran, S. J., Yamamoto, Y., Newton, C., Klein, T. W. and Friedman, H., Inhibition of Legionella pneumophila growth by interferon in permissive A/J mouse macrophages: Role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect. Immun. 1994. 62: 3197-3205.
57. Cummings, K. L. and Tarleton, R. L., Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect. Immun. 2004. 72: 4081-4089.
58. von Loewenich, F. D., Scorpio, D. G., Reischl, U., Dumier, J. S. and Bogdan, C., Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur. J. Immunol. 2004. 34: 1789-1797.
59. Sun, Y.-H., den Hartigh, A. B., Santos, R. L., Adams, L. G. and Tsolisi, R. M., virB-mediated survival of Brucella abortus in mice and macrophages is independent of a functional inducible nitric oxide synthase or NADPH oxidase in macrophages. Infect. Immun. 2002. 70: 4826-4832
60. Igietseme, J. U., Perry, L. L., Ananaba, G. A., Uriri, I. M., Ojior, O. O., Kumar, S. N. and Caldwell, H. D., Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun. 1998. 66: 1282-1286.
61. Nelson, D. E., Virok, D. P.,Wood, H.,Roshick, C., Johnson, R. M., Whitmir, W. M., Crane, D. D. et al., Chlamydial IFN-γ immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. USA 2005. 102: 10658-10663.
62. Beaman, L., and Beaman, B. L., The role of oxygen and its derivatives in microbial pathogenesis and host defense. Annu. Rev. Microbiol. 1984. 38: 27-48.
63. Pais, T. F., Cunha, J. F. and Appelberg, R., Antigen specificity of T-cell response to Mycobacterium avium infection inmice. Infect. Immun. 2000. 68: 4805-4810.
64. Morrissey, J. H., Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity. Anal. Biochem. 1981. 117: 307-310.
65. Andersen, P. and Heron, I., Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect. Immun. 1993. 61: 844-851.